Genome-wide CRISPR screen identifies ELP5 as a determinant of gemcitabine sensitivity in gallbladder cancer

Journal: Nature Communications

Published: 2019-12-02

DOI: 10.1038/s41467-019-13420-x

Affiliations: 3

Authors: 14

Go to article
Institutions Share
Renji Hospital, SJTU, China 0.86
Shanghai Key Laboratory of Tumor Microenvironment and Inflammation, SJTU, China 0.14

Return